EDGAR Filing Documents for 0000950123-18-009382

Form DRS - Draft Registration Statement:

SEC Accession No. 0000950123-18-009382

Filing Date

2018-09-10

Accepted

2018-09-10 17:25:03

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS	2017059
2		filename2.htm	EX-3	123656
3		filename3.htm	EX-3	37988
4		filename4.htm	EX-4	1568258
5		filename5.htm	EX-10	209641
6		filename6.htm	EX-10	385976
7		filename7.htm	EX-10	340258
8		filename8.htm	EX-10	16696
9		filename9.htm	EX-10	372907
10		filename10.htm	EX-10	102551
11		filename11.htm	EX-10	20498
12		filename12.htm	EX-10	24888
13	GRAPHIC	g608943ex10.jpg	GRAPHIC	3778
14	GRAPHIC	g608943ex9.jpg	GRAPHIC	3293
15	GRAPHIC	g608943sp38.jpg	GRAPHIC	68515
16	GRAPHIC	g617454g00t08.jpg	GRAPHIC	90099
17	GRAPHIC	g617454g02l10.jpg	GRAPHIC	108493
18	GRAPHIC	g617454g26k67.jpg	GRAPHIC	61928
19	GRAPHIC	g617454g35i21.jpg	GRAPHIC	149024
20	GRAPHIC	g617454g55e09.jpg	GRAPHIC	190872
21	GRAPHIC	g617454g68r45.jpg	GRAPHIC	146981
22	GRAPHIC	g617454g84b16.jpg	GRAPHIC	74453
	Complete submission text file	0000950123-18-009382.txt		6458782

Mailing Address 509 S. EXETER ST., SUITE 202 BALTIMORE MD 21202

Business Address 509 S. EXETER ST., SUITE 202 BALTIMORE MD 21202 212-956-1111

Centrexion Therapeutics Corp (Filer) CIK: 0001592052 (see all company filings)